Skip to content
Companies

EMGenisys

Smartphone video scoring of livestock embryo viability

Raised to date

$521K

of $1.5M offered across 1 Form D filing

Still open
$979K
Investors
4
Last filed
Mar 24, 2026

About

EmGenisys develops non-invasive embryo analysis technology for livestock reproductive programs. Its platform captures a short video of embryos in culture media through a smartphone mounted on a standard microscope and uses machine learning and computer vision to score embryo health and viability in seconds. The assessment is designed to run either in the lab or chute-side, replacing subjective visual grading with objective, data-driven output. The company was founded by veterinary and animal-science researchers and won the BioTools Innovator grand prize in 2024.

Assesses embryo health non-invasively from a 30-second smartphone video on equipment breeders already own, returning objective viability results in seconds where the industry standard is subjective visual grading by an embryologist.

Funding

  • EquityFiled Mar 24, 2026Form D/A
    $521K/ $1.5M

Product

EmVision

Animal reproductive technology software

A software platform that analyzes a 30-second video of embryos in culture media, captured via a smartphone on a standard microscope, and returns a machine-learning-derived health and viability assessment.

  • Non-invasive analysis from a 30-second video, no embryo biopsy required
  • Machine learning and computer vision scoring of embryo health
  • Works with a smartphone on a standard laboratory microscope

Built for

Livestock producers, cattle breeders, veterinarians and embryo transfer facilities running assisted reproductive technology programs

People on file